P. Noble
Pulmonary and Respiratory Medicine · 2001–2014
A researcher in the Science corpus: 16 papers; trusts 4 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Pulmonary and Respiratory Medicine — 43 citations into it; #389 of 770 by trust here, #45 by citations
- Immunology — 41 citations into it; #1,099 of 2,160 by trust here, #729 by citations
- Cancer Research — 18 citations into it; #1,423 of 1,780 by trust here, #1,358 by citations
- Oncology — 10 citations into it
- Immunology and Allergy — 9 citations into it; #158 of 206 by trust here, #135 by citations
Whom P. Noble trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts P. Noble overall
Papers from P. Noble's perspective
Ordered by how strongly the researchers P. Noble trusts endorse each paper. Same corpus, a different order for every researcher.
- Resolution of Lung Inflammation by CD44 (Science)
- Toll-like receptors. (Critical Care Medicine)
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 (Journal of Experimental Medicine)
- Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. (Journal of Clinical Investigation)
- Toll-like receptor 4 polymorphisms and atherogenesis. (New England Journal of Medicine)
- The six hyaluronidase-like genes in the human and mouse genomes. (Matrix Biology)
- Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways (Nature Medicine)
- IRAK-M is a negative regulator of Toll-like receptor signaling. (Cell)
- Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation (Nature Medicine)
- Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR21 (Journal of Immunology)
Their papers
- Hyaluronan in tissue injury and repair. (2007) — 869 citations
- Signaling Properties of Hyaluronan Receptors* (2002) — 1,046 citations
- Hyaluronan as an Immune Regulator in Human Diseases (2011) — 1,034 citations
- Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. (2011) — 1,047 citations
- A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (2014) — 2,093 citations
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. (2014) — 2,107 citations
- Type 2 alveolar cells are stem cells in adult lung. (2013) — 1,558 citations
- Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition (2011) — 959 citations
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. (2011) — 2,026 citations
- CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. (2006) — 678 citations
- Regulation of lung injury and repair by Toll-like receptors and hyaluronan (2005) — 1,456 citations
- The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis (2005) — 596 citations
- A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. (2004) — 608 citations
- Resolution of Lung Inflammation by CD44 (2002) — 725 citations
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (2002) — 3,677 citations
- Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 (2001) — 993 citations